Will Denver soon become the new Amsterdam? Since January, Colorado residents have no longer needed to fly to the Netherlands to legally purchase and imbibe marijuana for recreational uses. While 18 other states including California have legalized the drug for medicinal purposes, Colorado is only one of two states (the other being Washington) where citizens can legally light up for fun.

Yet when it comes to the Colorado marijuana industry, business may be getting in the way of pleasure – especially for investors buying up stock in companies who do business in the drug.

Last week, the Securities and Exchange Commission suspended trading at Denver-based Fusion Pharm Inc. (FSPM), a company who sells “indoor commercial cultivation solutions.” The company dubiously touts its “plug and grow” devices, PharmPods, as the “most exciting thing since the KFC Double Down.”

Why the crackdown? In the case of Fusion Pharm, the SEC raised concerns regarding the company’s financial statements, assets and revenues, calling into question the overall accuracy of its stated financial picture.

Approach With Caution

This isn’t an isolated case. Investors hungry to jump into the marijuana market may want to stave off the munchies and consider the recent slew of SEC suspensions among cannabis micro-cap companies: at least five have been forced to halt trading in the past several months. SEC officials have warned investors to approach potential investments in this arena with prudence.

Due to growing concerns about potential abuses in the micro-cap market, the SEC formed a task force to proactively address unlawful practices. Companies in the market will generally show modest assets, as well as low – and often unstable – stock prices, making them a risky proposition for investors even aside from the potential for fraud.

Inevitably, as state marijuana laws continue to evolve, new windows for fraud will open. With an increase in stock fraud among marijuana companies on the rise, securities regulators have warned consumers about penny stock fraud, illegal sales, and companies that have convicted criminals holding leadership positions.

Illegal practices surfaced, perhaps unsurprisingly, not long after the marijuana market’s emergence as a legal business in many states. As far back as last summer, allegations of “pump and dump” stock schemes were among the allegations made by the Financial Industry Regulatory Authority (FINRA), warning investors to look out for companies practicing unlawful market manipulation.

The Bottom Line:

When it comes to the quickly evolving marijuana sector, stay wary, heed SEC warnings and do your research. Without exercising due diligence, investing in the volatile micro-cap market could end up being as prudent as rolling your money and smoking it.

Related Articles
  1. Markets

    A Look At 2014's Leading Cannabis Stocks (Part II)

    This is the second missive of a two-part series on cannabis stocks in 2014.
  2. Markets

    A Look At 2014's Leading Cannabis Stocks (Part I)

    Even though cannabis-sector stocks have dropped more than 50 percent since the March peak, the Benzinga 420 Marijuana Index is still up 244 percent YTD.
  3. Mutual Funds & ETFs

    ETF Analysis: BioShares Biotechnology Products

    Learn more about the BioShares Biotechnology Products fund, an exchange-traded fund that is focused on producers of FDA-approved drugs.
  4. Investing News

    Valeant Pharmaceuticals acquires Sprout Pharmaceuticals

    On August 20, 2015, Valeant Pharmaceuticals (VRX) announced that they entered into definitive agreement to acquire Sprout Pharmaceuticals, that makes pink libido pill – Addyi.
  5. Mutual Funds & ETFs

    What You Need To Know About Bond ETF Yields

    When it comes to fixed income investing, yield is an important component of a bond investment’s total return to accurately assess if it's the right move.
  6. Professionals

    SEC Audit? No Problem (If You're Prepared)

    Audits are unwanted and unpleasant, but by getting your proverbial ducks in a row ahead of time you can ease and simplify the process.
  7. Stock Analysis

    Drugmaker Extraordinaire: How Eli Lilly Grows

    Drugs mean big profits in America. Here's how the country's oldest pharmaceutical firm keeps its toehold in the market.
  8. Professionals

    Is Your Financial Advisor Looking Out for You?

    Financial advisors sometimes aren't looking out for clients' best interests. Regulators are scrutinizing their practices; investors should too.
  9. Professionals

    Is a Google Robo-Advisor on the Horizon?

    It's possible that Google is looking to get into the robo-advisor business, either as a new venture or as a way to provide more benefits to employees.
  10. Investing Basics

    Is Your Broker Churning Your Account?

    Is your broker churning your account to generate fees? Here's how to know and what recourse you have.
  1. Orphan Drug

    A drug or biological product that treats a rare condition or ...
  2. Comprehensive Automated Risk Data ...

    The Comprehensive Automated Risk Data System (CARDS) is an initiative ...
  3. Restricted Stock

    Insider holdings that are under some other kind of sales restriction. ...
  4. Red Herring

    A preliminary prospectus filed by a company with the Securities ...
  5. Jumpstart Our Business Startups ...

    An act signed into law on April 5, 2012 that allays the regulations ...
  6. Investment Counsel Association ...

    A non-profit organization whose members work in the investment ...
  1. What are the disclosure requirements for a private placement?

    The U.S. Securities and Exchange Commission (SEC) has set forth disclosure requirements for private placements, including ... Read Full Answer >>
  2. What role does the Inspector General play with the Securities and Exchange Commission?

    The inspector general of the U.S. Securities and Exchange Commission (SEC) oversees, audits and conducts investigations of ... Read Full Answer >>
  3. How long does it take to execute an M&A deal?

    Even the simplest merger and acquisition (M&A) deals are challenging. It takes a lot for two previously independent enterprises ... Read Full Answer >>
  4. How is trading volume regulated by the Securities and Exchange Commission (SEC)?

    The U.S. Securities and Exchange Commission (SEC) has trading volume as a requirement for selling securities that are otherwise ... Read Full Answer >>
  5. What do I do if I think an accountant is in violation of the Generally Accepted Accounting ...

    The Financial Accounting Standards Board (FASB) promulgates generally accepted accounting principles (GAAP) in the United ... Read Full Answer >>
  6. What action is the SEC likely to take on 12b-1 fees?

    The Securities and Exchange Commission (SEC) may take action to impose greater regulation on how 12b-1 fees are used, or ... Read Full Answer >>

You May Also Like

Trading Center

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!